Displaying 21 - 40 of 1043 results

FY 2016 Budget Request

https://www.niams.nih.gov/es/node/1840

Statement for the Record Senate Subcommittee on Labor-HHS-Education Appropriations June 15, 2015 Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s fiscal year (FY) 2016 budget request for the

FY 2015 Congressional Justification

https://www.niams.nih.gov/es/node/1843

March 2014 Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the PHS Act with respect to arthritis and musculoskeletal and skin diseases, [$520,053,000]

FY 2012 Budget Request

https://www.niams.nih.gov/es/node/1844

Statement to the Senate Appropriations Subcommittee May 11, 2011 (historical) Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Fiscal Year 2012 Budget for the National Institute of Arthritis

Applying for a Grant

https://www.niams.nih.gov/es/node/1334

Applying for a grant can be challenging - understanding the process can help. The resources on this page provide information on NIAMS’s grant application guidelines and policies, and resources to learn more about the NIH grant process.

Grant Review Process

https://www.niams.nih.gov/es/node/1336

Applications submitted for funding by NIAMS undergo a rigorous review process. All applications are initially received by the Division of Receipt and Referral in the Center for Scientific Review (CSR) and then assigned to an Institute and Scientific Review Group for peer review. The majority of applications submitted to NIH

No-Cost Extensions

https://www.niams.nih.gov/es/node/1337

At NIH, generally all recipients may extend the final budget period of the previously approved project period one time for a period of up to 12 months beyond the original expiration date shown in the Notice of Award, if, as referenced in the NIH Grants Policy Statement: No additional funds

Conducting Clinical Trials

https://www.niams.nih.gov/es/node/1343

The NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. Clinical trials range from small

Exploratory Clinical Trial Grants (R61)

https://www.niams.nih.gov/es/node/1346

The Exploratory Clinical Trial Grant Program fosters the development and implementation of interventional exploratory clinical trials aimed at providing clinically meaningful improvements in symptoms, function or disease course for patients with rheumatic, musculoskeletal or skin diseases. The trials must address research questions related to the mission and goals of the

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01)

https://www.niams.nih.gov/es/node/1348

This Notice of Funding Opportunity (NOFO) encourages Research Project Grant (R01) applicants to pursue clinical observational (CO) studies to obtain data necessary for designing future clinical studies for musculoskeletal, rheumatic, or skin diseases or conditions. Research data from observational studies can enhance clinical study design by providing essential information about

Registering with ClinicalTrials.gov

https://www.niams.nih.gov/es/node/1356

ClinicalTrials.gov is a consumer-friendly database with information on clinical studies funded and/or sponsored by the NIH, other federal agencies, and private industry. The database was developed by NIH, through its National Library of Medicine (NLM), in collaboration with the Food and Drug Administration (FDA). The Food and Drug Administration Amendments

Typically materials from NIAMS that are more than 5 years old will be archived.